Becton, Dickinson and CompanyBDX, popularly known as BD, recently announced that the FDA has granted 510(k) clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System. Anticipated to ...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the EnCor EnCompass Breast ...

State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026 FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading ...